Hide metadata

dc.date.accessioned2018-09-13T14:11:59Z
dc.date.available2018-09-13T14:11:59Z
dc.date.created2016-03-29T10:05:33Z
dc.date.issued2016
dc.identifier.citationLysdahl, Kristin Bakke Hofmann, Bjørn . Complex health care interventions: Characteristics relevant for ethical analysis in health technology assessment. GMS Health Technology Assessment. 2016, 12
dc.identifier.urihttp://hdl.handle.net/10852/64720
dc.description.abstractComplexity entails methodological challenges in assessing health care interventions. In order to address these challenges, a series of characteristics of complexity have been identified in the Health Technology Assessment (HTA) literature. These characteristics are primarily identified and developed to facilitate effectiveness, safety, and cost-effectiveness analysis. However, ethics is also a constitutive part of HTA, and it is not given that the conceptions of complexity that appears relevant for effectiveness, safety, and cost-effectiveness analysis are also relevant and directly applicable for ethical analysis in HTA. The objective of this article is therefore to identify and elaborate a set of key characteristics of complex health care interventions relevant for addressing ethical aspects in HTA. We start by investigating the relevance of the characteristics of complex interventions, as defined in the HTA literature. Most aspects of complexity found to be important when assessing effectiveness, safety, and efficiency turn out also to be relevant when assessing ethical issues of a given health technology. However, the importance and relevance of the complexity characteristics may differ when addressing ethical issues rather than effectiveness. Moreover, the moral challenges of a health care intervention may themselves contribute to the complexity. After identifying and analysing existing conceptions of complexity, we synthesise a set of five key characteristics of complexity for addressing ethical aspects in HTA: 1) multiple and changing perspectives, 2) indeterminate phenomena, 3) uncertain causality, 4) unpredictable outcome, and 5) ethical complexity. This may serve as an analytic tool in addressing ethical issues in HTA of complex interventions.en_US
dc.languageEN
dc.language.isoenen_US
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleComplex health care interventions: Characteristics relevant for ethical analysis in health technology assessmenten_US
dc.typeJournal articleen_US
dc.creator.authorLysdahl, Kristin Bakke
dc.creator.authorHofmann, Bjørn
cristin.unitcode185,52,13,0
cristin.unitnameSenter for medisinsk etikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1347175
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=GMS Health Technology Assessment&rft.volume=12&rft.spage=&rft.date=2016
dc.identifier.jtitleGMS Health Technology Assessment
dc.identifier.volume12
dc.identifier.pagecount8
dc.identifier.doihttp://dx.doi.org/10.3205/hta000124
dc.identifier.urnURN:NBN:no-67246
dc.subject.nviVDP::Medisinske fag: 700
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1861-8863
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/64720/2/1347175.pdf
dc.type.versionPublishedVersion
cristin.articleidDoc01
dc.relation.projectEU/European Commission Grant agreement no. 306141


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International